As one of main regulators during EMT and metastasis, SNAI2 is often upregulated in various cancer types; high SNAI2 expression normally predicts poor prognosis in cancer patients, including HCC [5, 33, 34]. This evidence concerns the gene SNAI2 and hepatocellular carcinoma.